Compare SABS & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SABS | FCCO |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.4M | 228.0M |
| IPO Year | N/A | 2012 |
| Metric | SABS | FCCO |
|---|---|---|
| Price | $4.14 | $28.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.80 | N/A |
| AVG Volume (30 Days) | ★ 502.5K | 47.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | N/A | ★ 16.77 |
| EPS | N/A | ★ 1.85 |
| Revenue | N/A | ★ $952,000.00 |
| Revenue This Year | N/A | $30.67 |
| Revenue Next Year | N/A | $5.87 |
| P/E Ratio | ★ N/A | $15.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $19.46 |
| 52 Week High | $6.60 | $31.50 |
| Indicator | SABS | FCCO |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 35.13 |
| Support Level | $3.52 | $27.90 |
| Resistance Level | $4.68 | $29.73 |
| Average True Range (ATR) | 0.30 | 0.83 |
| MACD | 0.06 | -0.14 |
| Stochastic Oscillator | 36.11 | 17.36 |
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.